Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Radboud University Medical Center · Radboud University Nijmegen
Abstract
Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies.
After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved.
Citation impact
- FWCI
- 109.17
- Percentile
- 100%
- References
- 28
Authors
32- BDBen de Pauw
Radboud University Medical Center, Radboud University Nijmegen
- TJThomas J. Walsh
Radboud University Nijmegen, Radboud University Medical Center
- JPJ. Peter DonnellyCorresponding
Radboud University Nijmegen, Radboud University Medical Center
- DADavid A. Stevens
Radboud University Nijmegen, Radboud University Medical Center
- JEJohn E. Edwards
Radboud University Nijmegen, Radboud University Medical Center
Topics & keywords
- Medicine
- Disease
- Epidemiology
- Cancer
- Intensive care medicine
- Family medicine
- Pathology
- Internal medicine
- Good health and well-being
Funding
- AAmgen
- PPfizer
- GGlaxoSmithKline
- SSanofi
- GSGilead Sciences
- CHChildren's Hospital of Philadelphia
- WSWayne State University
- UOUniversity of Pennsylvania
- WTWellcome Trust
- VPValeant Pharmaceuticals International
- ECEuropean Commission
- UOUniversity of Aberdeen
- EOEuropean Organisation for Research and Treatment of Cancer
- APAstellas Pharma
- CHCentre Hospitalier Universitaire Vaudois
- BPBasilea Pharmaceutica
- IItalfarmaco
- NINational Institutes of Health
- UAUniversity at Buffalo
- MSMedical School, University of Michigan
- UOUniversity of Texas Health Science Center at San Antonio
- MRMedical Research Council
- NHNational Health and Medical Research Council
- NINational Institute of Allergy and Infectious Diseases
- JPJanssen Pharmaceuticals
- UPUCB Pharma
- DSDaiichi Sankyo Europe